- Home
- BBCP vs AVIR Comparison
BBCP vs AVIR Comparison
Compare BBCP & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBCP | AVIR |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 236.7M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BBCP | AVIR |
|---|---|---|
| Price | $7.00 | $3.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.50 | $6.00 |
| AVG Volume (30 Days) | 90.8K | ★ 362.8K |
| Earning Date | 01-08-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $395,562,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.28 | N/A |
| P/E Ratio | $42.73 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.78 | $2.46 |
| 52 Week High | $9.68 | $4.02 |
Technical Indicators
Market Signals| Indicator | BBCP | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 64.93 |
| Support Level | $6.85 | $3.11 |
| Resistance Level | $7.16 | $3.72 |
| Average True Range (ATR) | 0.24 | 0.12 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 83.71 | 73.17 |
Price Performance
Historical ComparisonAbout BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).